PATENT CLAIM ANALYSIS

Application Number: 16040592
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "278100"]

Abstract:
The invention provides compositions and methods for targeting CCR10 and/or the CCR10/ligand axis to modulate the immune response in a subject.

Claim (Index 10):
The method of  claim 9 , wherein the inhibitor is selected from the group consisting of a small interfering RNA (siRNA), a microRNA, an antisense nucleic acid, a ribozyme, an expression vector encoding a transdominant negative mutant, an antibody, a peptide and a small molecule.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 95.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14669663', '14764024', '11165091', '11335736', '14359764']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7878376033469358
- 35 USC 102 Novelty (BERT): 0.6019821588413282
- Combined Prediction Score: 0.7692520588963749
- Mean Citation Score: 350.110104
- Max Citation Score: 667.80365
- Similarity Product: 439.6275102463245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test